Strategic Wealth Management’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3.52M Hold
99,162
1.74% 20
2021
Q3
$3.48M Buy
99,162
+1,539
+2% +$55.7K 1.81% 16
2021
Q2
$3.42M Sell
97,623
-3,952
-4% -$132K 1.84% 20
2021
Q1
$3.29M Hold
101,575
1.97% 16
2020
Q4
$3.29M Sell
101,575
-400
-0.4% -$12.5K 2.02% 18
2020
Q3
$3.08M Buy
+101,975
New +$3.09M 2.3% 14

Other funds holding IEIH

Strategic Wealth Management's IEIH Position: Q4 2021 in Review

Strategic Wealth Management held its iShares Evolved U.S. Innovative Healthcare ETF (IEIH) position steady in Q4 2021 at 99,162 shares worth $3.52M. The position accounts for 1.74% of the portfolio, ranked #20.

Strategic Wealth Management first reported a position in IEIH in Q3 2020 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold IEIH as of Q4 2021.

  • Strategic Wealth Management held 99,162 shares of iShares Evolved U.S. Innovative Healthcare ETF worth $3.52M as of Q4 2021.
  • Strategic Wealth Management left its iShares Evolved U.S. Innovative Healthcare ETF share count unchanged in Q4 2021.
  • iShares Evolved U.S. Innovative Healthcare ETF made up 1.74% of Strategic Wealth Management's portfolio in Q4 2021, its #20 holding.
  • Strategic Wealth Management first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q3 2020 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q4 2021.

Based on Strategic Wealth Management's 13F filing for Q4 2021, filed 7 Feb 2022.